← Back to Search

Behavioral Intervention

Neurofeedback + TMS for Alcoholism (CNT Trial)

N/A
Waitlist Available
Led By Samantha J Fede, PhD
Research Sponsored by Auburn University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at weeks: 1 (baseline), 2-5 (intervention sessions), 9, 13, 17, 21, 25, 29, 33, 37, 41, 45, 49, 53, 57 (follow-ups)

Summary

This trial studies if MRI and TMS can help people with Alcohol Use Disorder. Participants will come in for 4 weeks of intervention and follow-up visits for up to a year.

Who is the study for?
This trial is for adults aged 19-65 who are currently receiving treatment for Alcohol Use Disorder. It's not suitable for those with significant head injuries, claustrophobia that prevents MRI scans, neurological diseases, seizure history, certain metal implants or body metal including facial tattoos, medications lowering seizure threshold, active alcohol withdrawal symptoms, hearing loss worsened by MRI/TMS or a family history of schizophrenia.
What is being tested?
The study tests if additional fMRI neurofeedback and TMS (Transcranial Magnetic Stimulation) can help people being treated for Alcohol Use Disorder. Participants will undergo weekly sessions over four weeks and have follow-ups via remote contact monthly up to one year with two extra MRI sessions at six and twelve months.
What are the potential side effects?
Potential side effects from the interventions may include discomfort from the TMS procedure like scalp pain or headache during and after treatment. The fMRI process is generally safe but might cause unease due to loud noises or confinement in the machine.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at weeks: 1 (baseline), 2-5 (intervention sessions), 9, 13, 17, 21, 25, 29, 33, 37, 41, 45, 49, 53, 57 (follow-ups)
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at weeks: 1 (baseline), 2-5 (intervention sessions), 9, 13, 17, 21, 25, 29, 33, 37, 41, 45, 49, 53, 57 (follow-ups) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Aggression and Victimization over Time
Ethanol
Alcohol Use Disorder
+5 more
Secondary study objectives
Brain
Brain
Change in Resting State Functional Connectivity over Time

Trial Design

5Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Neurofeedback-active + TMS-activeExperimental Treatment2 Interventions
4 sessions of: TMS (protocol: 10 Hz pulses delivered at 110% of MT in 60 x 5 sec trains with 25 sec ITI) Neurofeedback (protocol: presentation of own brain activity from multiple ROIs measured using fMRI)
Group II: Neurofeedback-active + TMS-shamActive Control2 Interventions
4 sessions of: TMS (protocol: 10 Hz pulses delivered using the Sham TMS coil in 60 x 5 sec trains with 25 sec ITI) Neurofeedback (protocol: presentation of own brain activity from multiple ROIs measured using fMRI)
Group III: Check-In OnlyActive Control1 Intervention
4 sessions of: Completing typical pre-TMS/MRI procedures Being prompted to reflect on outside treatment (TAU)
Group IV: Neurofeedback-sham + TMS-activeActive Control2 Interventions
4 sessions of: TMS (protocol: 10 Hz pulses delivered at 110% of MT in 60 x 5 sec trains with 25 sec ITI) Neurofeedback (protocol: presentation of other's brain activity from multiple ROIs measured using fMRI)
Group V: Neurofeedback-sham + TMS-shamPlacebo Group2 Interventions
4 sessions of: TMS (protocol: 10 Hz pulses delivered using the Sham TMS coil in 60 x 5 sec trains with 25 sec ITI) Neurofeedback (protocol: presentation of other's brain activity from multiple ROIs measured using fMRI)

Find a Location

Who is running the clinical trial?

Auburn UniversityLead Sponsor
80 Previous Clinical Trials
14,529 Total Patients Enrolled
1 Trials studying Alcoholism
87 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
839 Previous Clinical Trials
1,083,558 Total Patients Enrolled
459 Trials studying Alcoholism
823,741 Patients Enrolled for Alcoholism
Samantha J Fede, PhDPrincipal InvestigatorAuburn University
1 Previous Clinical Trials
40 Total Patients Enrolled

Media Library

Realtime fMRI Neurofeedback - Active (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05621538 — N/A
Alcoholism Research Study Groups: Neurofeedback-active + TMS-sham, Check-In Only, Neurofeedback-sham + TMS-active, Neurofeedback-active + TMS-active, Neurofeedback-sham + TMS-sham
Alcoholism Clinical Trial 2023: Realtime fMRI Neurofeedback - Active Highlights & Side Effects. Trial Name: NCT05621538 — N/A
Realtime fMRI Neurofeedback - Active (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05621538 — N/A
~52 spots leftby Mar 2026